Baird lowered Equifax's price target to 232 from 245 while keeping an Outperform rating, indicating a willingness to buy on weakness after a mixed quarterly update. Needham & Company also cut its target to 245 but Maintains a Buy rating, reflecting cautious optimism about upside potential. Other major banks, including Wells Fargo, Bank of America, Morgan Stanley, Mizuho, and Goldman Sachs, issued revised targets and ratings, with the market-wide view showing roughly thirteen analysts rated Buy and six Hold, and an average target around 218.32. Equifax reported its July 21 quarter with EPS of 2.25 on revenue of 1.70 billion, beating estimates and delivering a ROE near 20% with solid margins. The confluence of trims and defended ratings suggests investors face a mix of upside prospects and valuation concerns as analysts weigh the stock's trajectory. These reactions were reported across Benzinga, The Fly, Needham’s updates, and The Stock Observer, underscoring a broadly positive but selectively cautious sentiment toward Equifax.